**Charity Registra�on No. 326905**
**Company Registra�on No. 01892427 (England and Wales)**
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
**ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS**
**FOR THE YEAR ENDED 31 DECEMBER 2024**
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **LEGAL AND ADMINISTRATIVE INFORMATION**
|**Charity number**|326905|
|---|---|
|**Company number**|01892427|
|**Registered o�ce**|3rd Floor|
||Interchange place|
||151 - 165 Edmund Street|
||Birmingham|
||B3 2TA|
|**Independent examiner**|TC Group|
||Star House|
||Star Hill|
||Rochester|
||Kent|
||ME1 1UX|
|**Bankers**|Unity Trust Bank Plc|
||9 Brindley Place|
||Birmingham|
||B1 2HB|
|**Solicitors**|Wrigleys Solicitors LLP|
||19 Cockridge Street|
||Leeds|
||LS2 3AG|
**BRITISH & IRISH ORTHOPTIC SOCIETY**
## **CONTENTS**
||**Page**|
|---|---|
|Trustee's report|1 - 11|
|Independent examiner's report|12|
|Statement of �nancial ac�vi�es|13|
|Statement of �nancial posi�on|14 - 15|
|Notes to the �nancial statements|16 - 27|
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **TRUSTEE'S REPORT (INCLUDING DIRECTORS' REPORT)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
The trustees present their annual report and �nancial statements for the year ended 31 December 2024.
The �nancial statements have been prepared in accordance with the accoun�ng policies set out in note 1 to the �nancial statements and comply with the charity's [governing document], the Companies Act 2006 and "Accoun�ng and Repor�ng by Chari�es: Statement of Recommended Prac�ce applicable to chari�es preparing their accounts in accordance with the Financial Repor�ng Standard applicable in the UK and Republic of Ireland (FRS 102)" (e�ec�ve 1 January 2019).
## **Objec�ves and ac�vi�es**
## **Chair and Vice Chair Report**
The Bri�sh and Irish Orthop�c Society (BIOS) con�nues to meet the charitable aims through all of its ac�vi�es:
"The objects for which the Society is established are for the public bene�t to advance educa�on in orthop�cs and cognate subjects and to encourage the study and improve the prac�ce of orthop�cs with a view to maintaining and raising standards in clinical and scien��c orthop�cs.”
We have con�nued to represent the profession na�onally holding seats on the Allied Health Professions Federa�on Board, the Clinical Council for Eye Health Commission, The UK Ophthalmology Alliance Board, and the Royal College of Ophthalmologists Paediatric Sub Commi�ee. We have posi�vely engaged with the Regulator (HCPC) and contributed to a number of workstreams. We are also an ac�ve stakeholder in the crosssector Eye Care Workforce Dashboard, designed to inform future workforce planning.
Our second face-to-face Conference since Covid happened in June in Manchester, with brilliant a�endance across both days once again. The packed agenda included 36 presenta�ons over two days, as well as Q&As, poster presenta�ons and networking opportuni�es. The students presenta�ons session was once again a huge success, giving future orthop�sts an opportunity to present research in a suppor�ve atmosphere.
The event also saw the appointment of our new Vice Chair, Helen Haggerty, given an increased secondment of two days, in order to be�er support the opera�onal management of the Society. We also appointed four new Trustees - Jennifer Skillen in Scotland, Ma�hew Groogan in Northern Ireland, Liz Tomlin for the South of England. and Julie Dowdney was appointed as Chair of the Leaders of the Orthop�c Profession (LOOP).
A�er the AGM, we honoured the following Orthop�sts with BIOS awards for their dedica�on and service to BIOS in their voluntary roles:
## Contribu�ons to BIOS
- Hannah Harwood
- Sue Elliot
- Deborah Podmore
- Dipesh Patel
- Karzan Hughes
Fellowship
- Andrew Fox
- Beverley Harden
- Julie Dowdney
- Angela Carlin
- 1 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **TRUSTEE'S REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
We also awarded Professor Helen Davis OBE with our �rst ever Life�me Achievement Award, recognising her outstanding contribu�on to the orthop�c profession and unwavering commitment to and support of BIOS across her whole career.
2024 was the �rst full year of our new strategy, and there was a signi�cant focus on increasing the visibility of our profession. We created two new seconded posts for orthop�sts as BIOS Visibility leads, with a remit or increasing visibility and recruitment to the profession over the coming years.
We also launched a con�nua�on of the BIOS Orthop�c Workforce Development Programme, with signi�cant funding from NHS England for work spanning the profession across the whole of the UK and Ireland. The thirteen projects, across areas of educa�on and professional development, closely align with our strategic priori�es.
March 2024 saw BIOS move to independent opera�on with sta� members undergoing a TUPE process to be employed directly by BIOS. We con�nue to develop this capacity and are engaged in a con�nuing process of improvement of opera�onal resilience. We have also increased sta�ng, with the appointment of a Project Manager, to enable this as well as deliver on the projects in the NHSE commission.
We have con�nued to work towards the aim of orthop�sts gaining the right to prescribe spectacle correc�ons within hospital eye services. We commissioned a piece of research, to be submi�ed to the GOC in March 2025, compiling evidence and case studies to support this change.
The Trustees, Council, standing commi�ee members, clinical advisory group leads and other volunteers have con�nued to represent BIOS throughout 2024 in addi�on to suppor�ng their own colleagues in their full �me clinical, academic or research roles and we would like to thank them all for their con�nued support during this year.
## **Craig Murray – Chair BIOS**
## **Helen Haggerty – Vice Chair BIOS**
- 2 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **TRUSTEE'S REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **Review of ac�vi�es**
## **BIOS Trustees’ Report**
2024 was the �rst full year of our �ve-year strategy, launched at the 2023 Conference. In the Trustees’ report, we highlight our achievements in 2024 against the four key themes from our strategic plan: to develop BIOS’s opera�onal resilience; to lead the development of the profession; to improve visibility, recruitment and reten�on; and to lead innova�on within the profession.
## **Develop BIOS opera�onal resilience**
BIOS has con�nued to focus on ensuring the future of the Society through suppor�ng and represen�ng an involved and commi�ed membership.
## **BIOS Structural Changes**
The formal transi�on of sta� from the Bri�sh Diete�c Associa�on (BDA) to being directly employed by BIOS was completed in March. We now directly employ three permanent members of sta�, accountable to the Trustees via our Chair and Vice-Chair. As well as reducing costs, this enables us to be�er integrate these roles into our work and gives us the opportunity to further develop sta� to become long term assets to the Society.
## **BIOS Conference and AGMs 2024**
In July, we held our annual Conference and AGM in Manchester. This was a huge success, a�rac�ng over 200 members, well over 10% of our membership. We had 36 presenta�ons over two days, as well as Q&As, poster presenta�ons and networking opportuni�es.
Following feedback on the desire for more speci�cally clinical content, we have now developed plans for alterna�ng out Conference with a Symposium every other year. This one day event will con�nue to include some research, in par�cular the popular student presenta�ons, but will also include more clinical discussions. The �rst event is now arranged for June 2025 in Birmingham.
## **Advice and support**
All of our full members receive bespoke Medical & Professional Liability Insurance. The insurance o�ered through BIOS is also the only insurance that covers the en�re scope and extended scope of prac�ce by an orthop�st. We know how valuable this is to our members and are commi�ed to con�nuing to provide this.
Members in the UK also receive support from the BOS TU, providing representa�on and advice on work ma�ers from local BOS TU reps and Society O�cers and experts including grievance and disciplinary issues, and terms and condi�ons of employment.
## **Member Communica�ons**
We con�nue to work to improve our communica�on with members. In January we launched a new look version of Parallel Vision, our fortnightly e-zine, improving the look and accessibility as well as introducing a more consistent layout to help members �nd content relevant to them. We launched a member survey in April to gain insight into how members felt about our services. We followed this with our �rst ever Town Hall Mee�ng in October, a virtual event where we shared updates and gave members an opportunity to give feedback and ask ques�ons.
- 3 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **TRUSTEE'S REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
As part of the NHS England-funded workforce projects, we are now upda�ng the look and structure of our website to promote the visibility of the profession. We’re also taking the opportunity to add a new Customer Rela�onship Management (CRM) system, which will improve func�onality and ease of use for members.
## **Lead the development of the profession**
BIOS’s core work remains to ensure high standards across the orthop�c profession, through se�ng and maintaining standards and guidance, but also through iden�fying and suppor�ng the future development of orthop�cs.
## **Se�ng standards**
Our Educa�on and Professional Development Commi�ee (EPDC) and our CAGs con�nue to maintain up-to-date standards and competencies for our members. They also work with other organisa�ons in their �elds to produce collabora�ve guidelines and documenta�on.
Towards the end of 2024 the decision was made to create a new seconded post of Director of Educa�on to oversee and drive forward this vital work. We hope to appoint I �me of the next AGM in 2025.
## **Advanced Clinical Prac�ce**
We con�nue to work to support the advance clinical prac�ce (ACP) agenda within orthop�cs. We endorsed the shared professional statement from the Chief Allied Health Professions O�cers in each of the four UK countries on Advanced prac�ce in the allied health professions (AHPs).
In May we released a posi�on statement on recogni�on for trainee and Advanced Clinical Prac��oners under Agenda for Change. We asserted that Trainee Advanced Clinical Prac��oner posts should be AfC band 7, progressing to 8a and above (dependent on the scope of prac�ce), upon comple�on of a full Master’s degree. The lack of consistency with regard to AfC posts presents risks to the Orthop�c profession and employing NHS Trusts.
## **Support Workforce**
One of the projects under the Orthop�c Workforce Programme con�nued our work promo�ng the role of the support workforce within orthop�cs and ophthalmology. For AHP Support Workforce Week in November, we launched a new careers page for clinical assistant roles, including a careers video and new case studies. We’ve also surveyed orthop�c Heads across the UK to inform our future work in this area.
## **Workforce Survey**
We con�nue to update our knowledge of the nature of the orthop�c workforce, carrying out a further Heads Ques�onnaire in May and a Workforce Ac�vity Survey in November. As part of our Orthop�c Workforce Programme, we will be wri�ng a full workforce report to be released in April, which will iden�fy developments within the workforce and future needs.
We were also involved in the crea�on of a new UK Eye Care data Hub, which inform commissioners and employers, o�ering data driven insight to ensure services are appropriately sta�ed and future professionals are equipped with the necessary knowledge and skills to meet emerging challenges.
- 4 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **TRUSTEE'S REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **Equality, Diversity & Inclusion (EDI)**
In December we launched a new EDI Strategy iden�fying six objec�ves to create a more inclusive and suppor�ve environment for all members, students, and professionals in the orthop�c community. This includes se�ng up a clear structure under the EDI Lead, with the crea�on of new diversity networks and a focus on support for learners with disabili�es.
In November we ran a Virtual Co�ee morning to gain feedback on our planned strategy and give members an opportunity to feed into our work and share experiences.
## **Independent Prescribing**
A year on form the launch of our Prescribing now campaign, calling for the extension of independent prescribing responsibili�es to orthop�sts and other AHPs, we sent a le�er to the then Secretary of State for Health and Social Care, Victoria Atkins MP on the importance of extending independent prescribing responsibili�es to orthop�sts to enable them to provide more �mely care for pa�ents and to be�er support over-stretched eye health services.
We then took the opportunity of AHPs day in October to relaunch the campaign to focus on the incoming government, be delivering a le�er in person to the new Secretary of State Wes Stree�ng, reitera�ng our call for the government to start the process for our professions.
## **Child Vision Screening**
In March we completed our survey of child vision screening services across England, highligh�ng the growing number of local authori�es not o�ering any form of screening. This was presented in an interac�ve map on our website, and we con�nue to raise awareness and lobby for such services to be made mandatory.
## **Refrac�on**
As part of our Workforce Programme, we completed a report for the General Op�cal Council (GOC), making the case for the extension of the responsibility to prescribe glasses to orthop�sts within hospital eye care services. We con�nue to collect evidence rela�ng to this in prepara�on for a likely consulta�on later in 2025.
## **Improve visibility, recruitment & reten�on**
We have con�nued to emphasise the need to increase the visibility of orthop�cs, ac�vely represen�ng orthop�c professionals at all levels, but also suppor�ng recruitment to ensure the future of the profession.
## **Visibility**
We have con�nued to work hard throughout 2024 to promote awareness or orthop�cs and the valuable work done by Orthop�sts, as well as to make ourselves a hub for accessible informa�on about eye care and orthop�c services.
In Autumn we appointed to two new seconded posts as Visibility Leads, to increase our capacity to raise awareness of the visibility of the profession among the general public and to prospec�ve orthop�cs students. A great deal or work has already been done to develop resources and materials for campaign in 2025.
We have con�nued to have a strong social media presence, thanks largely due to the work of our members in sharing, liking and retwee�ng.
- 5 -
**BRITISH & IRISH ORTHOPTIC SOCIETY**
## **TRUSTEE'S REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
- On X, we made almost 144,000 impressions, and our followers increased to 2597.
- Our Facebook page con�nues to grow steadily, reaching 1070 followers by the end of the year. Our posts had over 181,000 views in 2024.
- Our LinkedIn page remains rela�vely new but we’ve made a concerted e�ort to increase our reach, resul�ng in a 73% increase in followers to over 1,500, and 117,000 impressions, doubling the previous year for the second �me running.
In June, coinciding with World Orthop�c Day, we also relaunched our Instagram account as a main channel for communica�ng, rather than having an exclusive focus on careers. This had already resulted in over 1,350 followers by the end of the year and almost 105,000 impressions.
World Orthop�c Day also saw the launch of a new video, ‘Orthop�sts make a di�erence’ hosted in a newly expanded area of the website highligh�ng the impact of orthop�sts. The video acquired over 12,000 views on Instagram alone.
Much of our content on social media is aimed at growing awareness of our website, providing a hub for informa�on on orthop�cs in the UK and Ireland. We had over 800,000 user engagements in 2024, with over 6,450 visitors each month. Our visibility on search engines has con�nued to increase with over 61,000 clicks through from Google and 2.1 million impressions. This has led to a con�nued increase in visits to our public informa�on pages, with over 175,000 user engagements. Much of this work will be further supported by the launch of a new website in 2025.
## **Recruitment**
In prepara�on for our new website and the development of a career development framework, we have refocused our careers pages around the poten�al to develop throughout a career in orthop�cs, highligh�ng clinical assistant roles, enhanced and advanced roles and roles in research and educa�on, alongside core orthop�c roles.
We’ve also worked to refresh our network of departments o�ering work shadowing opportuni�es, mapping these departments with details on their applica�on processes to help prospec�ve applicants �nd appropriate placements.
The Orthop�c Appren�ceship Standard was signed o� in 2024. We are currently working to iden�fy an HEI to head up the new course, with an expected start date of 2026.
## **Represen�ng the profession**
BIOS also plays a signi�cant role in represen�ng the profession in a number of formal and informal bodies and groupings. For example, we are represented on the AHPF Board and policy groupings, the Royal College Ophthalmologists’ paediatric subcommi�ee, the Eye Health Forum, the UK Ophthalmology Alliance, along with a seat on the Clinical Council for Eye Health Commissioning (CCEHC).
BIOS remain a�liated to both the Orthop�stes de la Communauté Européenne (OCE), represen�ng Orthop�sts in Europe, and the Interna�onal Orthop�c Associa�on (IOA), giving us representa�on in important interna�onal discussions a�ec�ng our members.
BIOS represents Orthop�sts across all four countries of the United Kingdom and in the Republic of Ireland. Many of the issues facing our members will be common across the UK and Ireland. However, through all our work we look to provide representa�on and support that recognises the di�erences in the contexts within which our members are working. As such, the role of our regional and country Trustees is essen�al.
- 6 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **TRUSTEE'S REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
In 2024 we responded to a number of consulta�ons and calls for evidence on behalf of our members:
- In June, following the announcement of the HCPC fee increase, we raised concerns about the e�ect of the proposed increase on our members as well as raising further concerns about the service provided by the Council.
- We responded to the consulta�on from the Northern Ireland Department for Health on Safe and E�ec�ve Sta�ng Legisla�on Considera�ons, suppor�ng the principles but highligh�ng the need for con�nued engagement to ensure their successful implementa�on.
- We responded on behalf of our members to the Change NHS consulta�on on a new 10 year plan for England, highligh�ng the importance of orthop�sts and investment in eye care services.
In September we wrote to the new Secretary of State for Health and Social Care, Wes Stree�ng, highligh�ng the importance of Orthop�sts in suppor�ng eye care services, and calling on the new government to take steps to support the profession.
## **Lead innova�on within the profession**
We con�nue to invest in promo�ng innova�on within the profession, including ongoing CPD, research by orthop�sts, and innova�ons within orthop�c educa�on and prac�ce-based learning (PBL).
## **CPD and Networking**
Our Clinical and non-Clinical Advisory Groups (CAGs and nCAGs) along with the Trustees have con�nued to host both virtual and face-to-face events, enabling more members to access CPD, both on the day and via the recordings provided for free to members. BIOS held 32 events in 2024, including study days, regional mee�ngs and discussion events, with over 1,400 places booked.
Some of the highlights were:
- Our annual Na�onal Clinical Tutors Day in Glasgow in May a�racted tutors from departments across the UK to discuss simulated learning and increased support for tutors as we look to increase placement capacity.
- The Leaders of the Orthop�c Profession (LOOP) mee�ng at Moor�elds was popular as ever, including discussions on service development, the new workforce survey, and the surgical squint pathway.
- Our March Special Educa�onal Needs Annual Mee�ng, came at a vital �me, upda�ng on developments to the Special School Eyecare Service. A separate event was held towards the end of the year to support members looking to respond to the tender.
- The Stroke and Neuro-Rehab study day was extremely popular with over 60 members a�ending to discuss na�onal guidelines and share brag and steal short presenta�ons.
- Our Orthop�c Support Workforce Webinar, held in November to coincide with Na�onal AHP Support Workforce Week celebrated the impact of this vital part of the workforce, and saw the launch of our new careers resources.
We con�nue to provide recordings of all of our online CPD free to access for all BIOS members, with a further 17 event recordings added to our CPD Library.
- 7 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **TRUSTEE'S REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **Orthop�c Educa�on Fund (OEF)**
The OEF provides mall grants to orthop�c professionals and students to support them with educa�on and training. In 2024 we gave out £5,039 to seven members, to support students facing hardship and also to fund conference a�endance and post-graduate modules.
## **Research**
We con�nue to promote and support Orthop�sts involved in research, to support their career development but also to advance Bri�sh orthop�cs na�onally and interna�onally. We created a new role as a deputy research director, re�ec�ng our commitment to suppor�ng research.
We again awarded a joint £15,000 research grant with Fight For Sight to support orthop�c research. We also funded two places on the Royal College of Ophthalmology’s Research Changes Lives seminar to encourage new researchers.
## **Bri�sh and Irish Orthop�cs Journal (BIOJ)**
BIOJ, the o�cial journal of BIOS, has come to be recognised as an authorita�ve resource in areas related to clinical ocular mo�lity, visual func�on, amblyopia, binocular vision and strabismus. It published 25 ar�cles in 2024. Fully open-access, the BIOJ website received over 3,000 page views a month.
## **Prac�ce-Based Learning (PBL)**
We relaunched the already highly successful Hololens and Placement Expansion Resource Library (PERL) project in September. This included an expansion and refresh of the informa�on available on the website as well as promo�onal materials with quotes from tutors and Heads. We’ve also hosted a number of drop in sessions to o�er support to members looking to start recording videos for PERL and live streaming within their departments.
## **Financial review**
The Society reports a net surplus of £138,777 for the year (2023 – net surplus of £19,783). Free reserves at 31 December 2024 were £69,878 (2023 - £88,251). Restricted funds at 31 December 2024 amounted to £974,748 (2023 - £817,598). During the year, total income was £773,236, comprised of income from grants, membership subscrip�ons and course income. Total expenditure was £658,834 which comprised of unrestricted spend of £408,032 and restricted spend of £250,802.
The charity is looking into further opportuni�es from 2025 to support the long term vision of a sustainable, thriving and visible profession dedicated to the improvement of the eye health of the popula�on. Funding prospects are in place to increase capacity and reach for future projects.
## **Going concern**
A�er making appropriate enquiries, the trustees have a reasonable expecta�on that the charity has adequate resources to con�nue in opera�onal existence for the foreseeable future. For this reason they con�nue to adopt the going concern basis in preparing the �nancial statements. Further details regarding the adop�on of the going concern basis can be found in the Accoun�ng Policies.
- 8 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **TRUSTEE'S REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **Reserves policy**
The Trustees have considered the level of ac�vity within the charity and believe a level of free reserves of £235,000 is su�cient to support the ongoing opera�on of the society in the foreseeable future. At 31 December 2024, the Society has free reserves of £69,878 (2023 - £88,251). The Trustees are aware that this is below the stated target and are focused on replenishing these reserves over the coming years. The restricted reserves at 31 December 2024 is £974,748 and this will help support the charity objec�ves and projects in future years.
## **Structure, governance and management**
## **Cons�tu�on**
The company is registered as a charitable company limited by guarantee and was set up by a Memorandum of Associa�on on 14 March 1998.
The company is cons�tuted under a Memorandum of Associa�on dated 14 March 1998 and is a registered charity number 326905.
## **Method of appointment or elec�on of Trustees**
Trustees are recruited to represent members in England (3 regions), Scotland, Wales, Republic of lreland and Northern lreland. Nomina�ons are requested from all members and applica�on is in wri�ng with reference to a job descrip�on and job speci�ca�on. Where there is more than one candidate, applica�ons are circulated anonymously to vo�ng trustees. The Chair of the Leaders of the Orthop�c Profession (LOOP) is also a Trustee.
The vast majority of o�cers of the Society are volunteers and undertake BIOS work in addi�on to their day jobs. Only the Chair, and Vice Chair are seconded and their employers are reimbursed for their �me commitment to BIOS roles.
BIOS Council and Commi�ee O�cers/members - These appointments and roles were applicable in all or part of 2023:
## **BIOS Honorary O�cers and trustees**
Craig Murray - Chair Julie Dowdney (Jan-Jun 2024); Helen Haggerty (Jun-Dec 2024) - Vice Chair
## **BIOS Trustees**
Midlands & East – Rebecca Pinches (Jan-Dec 2024); Vacant (Dec 2024) Northern - Deborah Podmore Southern - Kelly MacKenzie (Jan-Jun 2024); Liz Tomlin (Jun-Dec 2024) Northern Ireland - Declan McClements (Jan-Jun 2024); Ma�hew Groogan (Jun-Dec 2024) Republic of Ireland - Claire McEntee Wales - Patrick Reedy (Jan-Jun 2024); Vacant (Jun-Dec 2024) Scotland - Angela Carlin (Jan-Jun 2024); Jennifer Skillen (Jun-Dec 2024) Leads of Orthop�c Profession Chair: Krishan Parmar (Jan-Jun 2024); Julie Dowdney (Jun-Dec 2024)
- 9 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **TRUSTEE'S REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **BOS TU Execu�ve Board**
General Secretary: Sam Aitkenhead President: Deborah Podmore Wales: Vacant Northern Ireland: Vacant Scotland: Vacant England: Joe Smith, John McBride and Vacant
## **BIOS Council members (non-vo�ng)**
Editor of Journal: Gemma Arblaster IOA Representa�ve: Jignasa Mehta OCE Representa�ve: Nadia Northway Research Director: Kerry Hanna
Educa�on and Professional Development Commi�ee Chair: Helen Davis (Jan-Jun 2024); Craig Murray & Julie Dowdney (Interim - Jun-Dec 2024) New Graduate Representa�ve: Holly Kniazewycz (Jan-Jun 2024); Madeleine Ellis (Jun-Dec 2024) Public Health Lead: Fiona Bush EDI Lead: Marian Owoniyi BOSTU (General Secretary): Sam Aitkenhead
## **Policies adopted for the induc�on and training of Trustees**
New trustees receive induc�on from the chair and vice chair and a copy of the Governance and Procedures Handbook, which become e�ec�ve from the start of the 2019 membership year.
## **Organisa�onal structure and decision making**
The honorary o�cers and BOSTU General Secretary are in regular communica�ons via email, telephone, Zoom and face-to-face when required to transact decision making work. Business is conducted via the business provider company who meet with the honorary o�cers regularly. Trustee mee�ngs are held 4 �mes per year and full council twice per year with an AGM in June to appoint new o�cers and agree the accounts.
## **Related party rela�onships**
The Society collects membership fees on behalf of the BOSTU. The society is a member of professional organisa�ons within the eye health and care sector.
- 10 -
**BRITISH & IRISH ORTHOPTIC SOCIETY**
## **TRUSTEE'S REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)**
_**FOR THE YEAR ENDED 31 DECEMBER 2024**_
including the income and expenditure, of the charitable company for that year.
-
with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence
The trustee's report was approved by the Board of Trustees.
wa .............................. **Craig Murray** Chair Dated: 6/8/2025
..............................
**Helen Haggerty** Vice-Chair Dated: 6/8/2025
- 11 -
**BRITISH & IRISH ORTHOPTIC SOCIETY**
## **INDEPENDENT EXAMINER'S REPORT**
## **TO THE TRUSTEES OF BRITISH & IRISH ORTHOPTIC SOCIETY**
I report to the trustees on my examina�on of the �nancial statements of Bri�sh & Irish Orthop�c Society (the charity) for the year ended 31 December 2024.
## **Responsibili�es and basis of report**
As the trustees of the charity (and also its directors for the purposes of company law) you are responsible for the prepara�on of the �nancial statements in accordance with the requirements of the Companies Act 2006 (the 2006 Act).
Having sa�s�ed myself that the �nancial statements of the charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examina�on, I report in respect of my examina�on of the charity’s �nancial statements carried out under sec�on 145 of the Chari�es Act 2011 (the 2011 Act). In carrying out my examina�on I have followed all the applicable Direc�ons given by the Charity Commission under sec�on 145(5)(b) of the 2011 Act.
## **Independent examiner's statement**
Since the charity’s gross income exceeded £250,000 your examiner must be a member of a body listed in sec�on 145 of the 2011 Act. I con�rm that I am quali�ed to undertake the examina�on because I am a member of the Associa�on of Chartered Cer��ed Accountants, which is one of the listed bodies.
I have completed my examina�on. I con�rm that no ma�ers have come to my a�en�on in connec�on with the examina�on giving me cause to believe that in any material respect:
- 1 accoun�ng records were not kept in respect of the charity as required by sec�on 386 of the 2006 Act; or
- 2 the �nancial statements do not accord with those records; or
- 3 the �nancial statements do not comply with the accoun�ng requirements of sec�on 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a ma�er considered as part of an independent examina�on; or
- 4 the �nancial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Prac�ce for accoun�ng and repor�ng by chari�es applicable to chari�es preparing their accounts in accordance with the Financial Repor�ng Standard applicable in the UK and Republic of Ireland (FRS 102).
In our opinion the �nancial statements have been been prepared in accordance with the requirements of the Trade Union and Labour Rela�ons (Consolida�on) Act 1992.
I have no concerns and have come across no other ma�ers in connec�on with the examina�on to which a�en�on should be drawn in this report in order to enable a proper understanding of the �nancial statements to be reached.
Sally Meah, FCCA On behalf of TC Group Star House Star Hill Rochester Kent ME1 1UX
Dated: .........................
- 12 -
**BRITISH & IRISH ORTHOPTIC SOCIETY**
## **STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
||||||As restated
As restated
As restated|As restated
As restated
As restated|
|---|---|---|---|---|---|---|
|||**Unrestricted**|**Restricted**|**Total**|**Unrestricted**
**Restricted**|**Total**|
|||**funds**|**funds**||**funds**
**funds**||
|||**2024**|**2024**|**2024**|**2023**
**2023**|**2023**|
||**Notes**|**£**|**£**|**£**|**£**
**£**|**£**|
|**Income and endowments from:**|||||||
|Dona�ons and legacies|**3**|-|268,750|268,750|-
-|-|
|Charitable ac�vi�es|**4**|364,948|139,202|504,150|356,171
125,511|481,682|
|Other income|**5**|336|-|336|1,175
-|1,175|
||||||||
|**Total income**||365,284|407,952|773,236|357,346
125,511|482,857|
||||||||
|Charitable ac�vi�es|**6**|408,032|250,802|658,834|406,807
94,486|501,293|
||||||||
|Net gains on|||||||
|investments||24,375|-|24,375|38,219
-|38,219|
||||||||
|**Net income/(expenditure) and**|||||||
|**movement in funds**||(18,373)|157,150|138,777|(11,242)
31,025|19,783|
|**Reconcilia�on of funds:**|||||||
|Fund balances at 1 January|||||||
|2024||88,251|817,598|905,849|99,493
786,573|886,066|
||||||||
|**Fund balances at 31 December**|||||||
|**2024**||69,878|974,748|1,044,626|88,251
817,598|905,849|
The statement of �nancial ac�vi�es includes all gains and losses recognised in the year. All income and expenditure derive from con�nuing ac�vi�es.
- 13 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **STATEMENT OF FINANCIAL POSITION**
## _**AS AT 31 DECEMBER 2024**_
|||**2024**|**2024**|**2023**|**2023**|
|---|---|---|---|---|---|
|||||**as restated**||
||**Notes**|**£**|**£**|**£**|**£**|
|**Fixed assets**||||||
|Tangible assets|**11**||15,796||19,973|
|Investments|**12**||270,516||257,422|
|||||||
||||286,312||277,395|
|**Current assets**||||||
|Debtors|**13**|26,136||25,802||
|Cash at bank and in hand||834,809||678,274||
|||||||
|||860,945||704,076||
|**Creditors: amounts falling due within one**|**14**|||||
|**year**||(102,631)||(75,622)||
|||||||
|**Net current assets**|||758,314||628,454|
|||||||
|**Total assets less current liabili�es**|||1,044,626||905,849|
|||||||
|**Net assets excluding pension liability**|||1,044,626||905,849|
|||||||
|||||||
|**The funds of the charity**||||||
|Restricted income funds|**15**||974,748||817,598|
|Unrestricted funds|||69,878||88,251|
|||||||
||||1,044,626||905,849|
- 14 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **STATEMENT OF FINANCIAL POSITION (CONTINUED)**
## _**AS AT 31 DECEMBER 2024**_
Act 2006, for the year ended 31 December 2024.
to the small companies regime.
.............................. .............................. Craig Murray **Trustee** Helen Haggerty **Vice-Chair**
- 15 -
**BRITISH & IRISH ORTHOPTIC SOCIETY**
_**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **NOTES TO THE FINANCIAL STATEMENTS**
## **1 Accoun�ng policies**
## **Charity informa�on**
Bri�sh & Irish Orthop�c Society is a private company limited by guarantee incorporated in England and Wales. The registered o�ce is 3rd Floor, Interchange place, 151 - 165 Edmund Street, Birmingham, B3 2TA.
## **1.1 Accoun�ng conven�on**
The �nancial statements have been prepared in accordance with the charity's [governing document], the Companies Act 2006 and "Accoun�ng and Repor�ng by Chari�es: Statement of Recommended Prac�ce applicable to chari�es preparing their accounts in accordance with the Financial Repor�ng Standard applicable in the UK and Republic of Ireland (FRS 102) (e�ec�ve 1 January 2019)". The charity is a Public Bene�t En�ty as de�ned by FRS 102.
The charity has taken advantage of the provisions in the SORP for chari�es applying FRS 102 Update Bulle�n 1 not to prepare a Statement of Cash Flows.
The �nancial statements are prepared in sterling, which is the func�onal currency of the charity. Monetary amounts in these �nancial statements are rounded to the nearest £.
The �nancial statements have been prepared under the historical cost conven�on. The principal accoun�ng policies adopted are set out below.
## **1.2 Going concern**
At the �me of approving the �nancial statements, the trustees have a reasonable expecta�on that the charity has adequate resources to con�nue in opera�onal existence for the foreseeable future. Thus the trustees con�nue to adopt the going concern basis of accoun�ng in preparing the �nancial statements.
## **1.3 Charitable funds**
Unrestricted funds are available for use at the discre�on of the trustees in furtherance of their charitable objec�ves.
Restricted funds are subject to speci�c condi�ons by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the �nancial statements.
Endowment funds are subject to speci�c condi�ons by donors that the capital must be maintained by the charity.
## **1.4 Incoming resources**
Income is recognised when the charity is legally en�tled to it a�er any performance condi�ons have been met, the amounts can be measured reliably, and it is probable that income will be received.
Cash dona�ons are recognised on receipt. Other dona�ons are recognised once the charity has been no��ed of the dona�on, unless performance condi�ons require deferral of the amount. Income tax recoverable in rela�on to dona�ons received under Gi� Aid or deeds of covenant is recognised at the �me of the dona�on.
Legacies are recognised on receipt or otherwise if the charity has been no��ed of an impending distribu�on, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a con�ngent asset.
- 16 -
**BRITISH & IRISH ORTHOPTIC SOCIETY**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **1 Accoun�ng policies**
## **(Con�nued)**
## **1.5 Resources expended**
Expenditure is recognised once there is a legal or construc�ve obliga�on to transfer economic bene�t to a third party, it is probable that a transfer of economic bene�ts will be required in se�lement and the amount of the obliga�on can be measured reliably.
All expenditure is accounted for on an accruals basis. All expenses including support costs and governance costs are allocated to the applicable expenditure headings. The cost of raising funds comprise investment management costs.
Support costs are those costs incurred directly in support of expenditure on the objects of the charity. Governance costs are those incurred in connec�on with administra�on of the charity and compliance with cons�tu�onal and statutory requirements.
## **1.6 Tangible �xed assets**
Tangible �xed assets are ini�ally measured at cost and subsequently measured at cost or valua�on, net of deprecia�on and any impairment losses.
Deprecia�on is recognised so as to write o� the cost or valua�on of assets less their residual values over their useful lives on the following bases:
Website 20% straight line O�ce Equipment 3 years straight line
The gain or loss arising on the disposal of an asset is determined as the di�erence between the sale proceeds and the carrying value of the asset, and is recognised in the statement of �nancial ac�vi�es.
## **1.7 Fixed asset investments**
Fixed asset investments are ini�ally measured at transac�on price excluding transac�on costs, and are subsequently measured at fair value at each repor�ng date. Changes in fair value are recognised in net income/(expenditure) for the year. Transac�on costs are expensed as incurred.
## **1.8 Financial instruments**
The charity has elected to apply the provisions of Sec�on 11 ‘Basic Financial Instruments’ and Sec�on 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its �nancial instruments.
Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.
Financial assets and liabili�es are o�set, with the net amounts presented in the �nancial statements, when there is a legally enforceable right to set o� the recognised amounts and there is an inten�on to se�le on a net basis or to realise the asset and se�le the liability simultaneously.
- 17 -
**BRITISH & IRISH ORTHOPTIC SOCIETY**
**NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **1 Accoun�ng policies**
## **(Con�nued)**
## _**Basic �nancial assets**_
Basic �nancial assets, which include debtors and cash and bank balances, are ini�ally measured at transac�on price including transac�on costs and are subsequently carried at amor�sed cost using the e�ec�ve interest method unless the arrangement cons�tutes a �nancing transac�on, where the transac�on is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classi�ed as receivable within one year are not amor�sed.
## _**Basic �nancial liabili�es**_
Basic �nancial liabili�es, including creditors and bank loans are ini�ally recognised at transac�on price unless the arrangement cons�tutes a �nancing transac�on, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabili�es classi�ed as payable within one year are not amor�sed.
Debt instruments are subsequently carried at amor�sed cost, using the e�ec�ve interest rate method.
Trade creditors are obliga�ons to pay for goods or services that have been acquired in the ordinary course of opera�ons from suppliers. Amounts payable are classi�ed as current liabili�es if payment is due within one year or less. If not, they are presented as non-current liabili�es. Trade creditors are recognised ini�ally at transac�on price and subsequently measured at amor�sed cost using the e�ec�ve interest method.
## _**Derecogni�on of �nancial liabili�es**_
Financial liabili�es are derecognised when the charity’s contractual obliga�ons expire or are discharged or cancelled.
## **1.9 Employee bene�ts**
The cost of any unused holiday en�tlement is recognised in the period in which the employee’s services are received.
Termina�on bene�ts are recognised immediately as an expense when the charity is demonstrably commi�ed to terminate the employment of an employee or to provide termina�on bene�ts.
## **2 Prior period adjustment**
Historically, income and expenditure rela�ng to the trade union were recorded through a trade union loan account, which re�ected a liability of £433,457 to the trade union as at 31 December 2023. Following a review of the accoun�ng treatment, the Board has concluded that a more appropriate approach is to recognise these transac�ons within the accounts as income and expenditure of a restricted fund. This re�ects the underlying substance of the arrangement, as the charity is expected to bear all future costs associated with the trade union, and the presenta�on as a loan does not accurately represent the economic reality.
The impact of this adjustment is an increase in restricted funds of £528,997, a reduc�on in creditors due within one year of £528,997, and a restatement of prior year income and expenditure by £125,511 and £41,161 respec�vely.
- 18 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **3 Dona�ons and legacies**
||||||**Restricted**|**Restricted**||Total|
|---|---|---|---|---|---|---|---|---|
|||||||**funds**|||
|||||||**2024**||2023|
|||||||**£**||£|
|Grants||||||268,750||-|
||||||||||
||||||||||
|**Income from charitable ac�vi�es**|||||||||
|**Unrestricted**||**Restricted**|**Total**|**Unrestricted**|**Restricted**|||**Total**|
||**funds**|**funds**||**funds**||**funds**|||
||**2024**|**2024**|**2024**|**2023**||**2023**||**2023**|
||**£**|**£**|**£**|**£**||**£**||**£**|
|Member's subscrip�ons|323,830|139,202|463,032|316,044||125,511||441,555|
|Course income|41,118|-|41,118|40,127||-||40,127|
||||||||||
||364,948|139,202|504,150|356,171||125,511||481,682|
## **4 Income from charitable ac�vi�es**
## **5 Other income**
||**Unrestricted**|**Unrestricted**|
|---|---|---|
||**funds**|**funds**|
||**2024**|**2023**|
||**£**|**£**|
|Adver�sing income|300|1,150|
|Sundry income|36|25|
||||
||336|1,175|
- 19 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **6 Charitable ac�vi�es**
||**Ac�vi�es**|**Ac�vi�es**|**Trade Union**|**Trade Union**||**Total**||**Total**|
|---|---|---|---|---|---|---|---|---|
|||||||**2024**||**2023**|
|||**2024**||**2024**|||||
|||**£**||**£**||**£**||**£**|
|Sta� costs||23,179||-||23,179||-|
|Secondment costs||274,599||31,025||305,624||156,345|
|Courses and conferences||51,233||-||51,233||33,359|
|Training costs||-||54||54||-|
|Journal||19,198||-||19,198||12,267|
|Contribu�on to awards||1,200||-||1,200||2,608|
|Bad debt provision||521||-||521||-|
|Travel and subsistence||-||2,176||2,176||2,974|
|Professional Fees||-||110||110||55|
|A�lia�on fees||-||9,588||9,588||6,454|
|Bank charges||-||36||36||36|
|Audit||-||672||672||672|
|Sta�onary & postage||-||-||-||608|
|Deprecia�on||-||-||-||344|
||||||||||
|||369,930||43,661||413,591||215,722|
|Share of support costs (see note 7)||177,067||-||177,067||225,091|
|Share of governance costs (see note 7)||68,176||-||68,176||60,480|
||||||||||
|||615,173||43,661||658,834||501,293|
||||||||||
||||||||||
|**Analysis by fund**|||||||||
|Unrestricted funds||408,032||-||408,032||406,807|
|Restricted funds||207,141||43,661||250,802||94,486|
||||||||||
|||615,173||43,661||658,834||501,293|
||||||||||
||||||||||
|**For the year ended 31 December 2023**|||||||||
|Unrestricted funds||406,807||-||||406,807|
|Restricted funds||83,343||11,143||||94,486|
||||||||||
|||490,150||11,143||||501,293|
- 20 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **7 Support costs allocated to ac�vi�es**
||**Charitable**|**Charitable**||**Total**||
|---|---|---|---|---|---|
||**ac�vi�es**|||||
|||**2024**||**2023**||
|||**£**||**£**||
|Deprecia�on||9,046||13,483||
|O�ce Costs||601||1,620||
|Insurance||48,098||46,537||
|Telephone and postage||1,014||3,948||
|Bank charges||5,513||5,360||
|Business management charges||43,276||117,193||
|Computer costs||59,173||17,753||
|Legal, professional and consultancy fees||-||(6,346)||
|Training costs||-||(616)||
|Adver�sing and marke�ng||10,346||12,601||
|Other consul�ng||-||12,036||
|Governance||68,176||60,480||
|||||||
|||245,243||284,049||
|||||||
|||||||
|||**2024**||**2023**||
|**Governance costs comprise:**||**£**||**£**||
|Accountancy||46,808||42,144||
|AGM, comi�ee and o�cer's expenses||21,368||18,336||
|||||||
|||68,176||60,480||
Independent examiner's remunera�on - £1,485 (2023 - £1,440) Independent examiner's remunera�on - accountancy - £2,055 (2023 - £1,995)
## **8 Trustees**
The trustees (or any persons connected with them) received remunera�on or bene�ts from the charity during the year as detailed in the Related Party Note 16 totalling £109,278 (2023 - £140,105).
During the year, 4 Trustees received £6,355 reimbursement of expenses (2023 - £1,317 to 7 Trustees).
- 21 -
**BRITISH & IRISH ORTHOPTIC SOCIETY**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **9 Employees**
The average monthly number of employees during the year was:
|||**2024**||**2023**|
|---|---|---|---|---|
||**Number**||**Number**||
|||3||-|
||||||
||||||
|**Employment costs**||**2024**||**2023**|
|||**£**||**£**|
|Wages and salaries||23,179||-|
There were no employees whose annual remunera�on was more than £60,000.
## **10 Taxa�on**
The charity is exempt from taxa�on on its ac�vi�es because all its income is applied for charitable purposes.
## **11 Tangible �xed assets**
|**Tangible �xed assets**||||||
|---|---|---|---|---|---|
||**WebsiteO�ce Equipment**||||**Total**|
||**£**||**£**||**£**|
|**Cost**||||||
|At 1 January 2024|67,419||2,387||69,806|
|Addi�ons|-||4,869||4,869|
|||||||
|At 31 December 2024|67,419||7,256||74,675|
|||||||
|**Deprecia�on and impairment**||||||
|At 1 January 2024|47,910||1,922||49,832|
|Deprecia�on charged in the year|7,441||1,606||9,047|
|||||||
|At 31 December 2024|55,351||3,528||58,879|
|||||||
|**Carrying amount**||||||
|At 31 December 2024|12,068||3,728||15,796|
|||||||
|||||||
|At 31 December 2023|19,508||465||19,973|
- 22 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **12 Fixed asset investments**
|**12**|**Fixed asset investments**||||
|---|---|---|---|---|
|||**Listed securi�es**|||
|||||**£**|
||**Cost or valua�on**||||
||At 1 January 2024|||257,422|
||Valua�on changes|||28,662|
||||||
||At 31 December 2024|||286,084|
||||||
||**Carrying amount**||||
||At 31 December 2024|||286,084|
||||||
||||||
||At 31 December 2023|||257,422|
||||||
||||||
||All the �xed asset investments are held in the UK.||||
|**13**|**Debtors**||||
|||**2024**||**2023**|
||**Amounts falling due within one year:**|**£**||**£**|
||Trade debtors|667||1,802|
||Other debtors|-||853|
||Prepayments and accrued income|25,469||23,147|
||||||
|||26,136||25,802|
||||||
||||||
|**14**|**Creditors: amounts falling due within one year**||||
|||**2024**||**2023**|
||||**As**|**restated**|
|||**£**||**£**|
||Trade creditors|12,375||13,592|
||Other creditors|3,070||3,053|
||Accruals and deferred income|87,186||58,977|
||||||
|||102,631||75,622|
- 23 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
|**14**|**Creditors: amounts falling due within one year**||**(Con�nued)**|
|---|---|---|---|
||**Deferred Income**|**£**|**£**|
||Deferred income at 1 January 2023|4,240|1,665|
||Resources deferred during the year|7,050|4,240|
||Amounts released from previous years|(4,240)|(1,665)|
||Deferred income at 31 December 2023|**7,050**|**4,240**|
- 24 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **15 Restricted funds**
The restricted funds of the charity comprise the unexpended balances of dona�ons and grants held on trust subject to speci�c condi�ons by donors as to how they may be used.
|||**Movement in funds**|**Movement in funds**||**Movement in funds**|**Movement in funds**||
|---|---|---|---|---|---|---|---|
||**Balance at**|**Incoming**|**Resources**|**Balance at**|**Incoming**|**Resources**|**Balance at**|
||**1 January 2023**|**resources**|**expended**|**1 January 2024**|**resources**|**expended**|**31 December**|
||||||||**2024**|
||**£**|**£**|**£**|**£**|**£**|**£**|**£**|
|AHP support||||||||
|worker|11,016|-|(1,604)|9,412|-|-|9,412|
|Clinical||||||||
|placement||||||||
|expansion|21,224|-|(3,054)|18,170|-|(101)|18,069|
|OBF||||||||
|Educa�on||||||||
|Fund|360,841|-|(5,071)|355,770|-|(3,847)|351,923|
|Appren�ceshi||||||||
|ps|44,386|-|(43,596)|790|-|-|790|
|NHSE Grant|-|-|-|-|268,750|(203,193)|65,557|
|Trade Union|349,106|125,511|(41,161)|433,456|139,202|(43,661)|528,997|
|||||||||
||786,573|125,511|(94,486)|817,598|407,952|(250,802)|974,748|
AHP Support Worker: this fund can be used to increase CPD and taking steps to promoted �exibility and career development.
Clinical placement expansion: this fund can be used to provide �nancial support and increase clinical placement opportuni�es.
OBF Educa�onal Fund: this fund can be used to provide �nancial support for the educa�on and further training of Orthop�sts.
Appren�ceships: this fund can be used to develop the support worker roles and responsibili�es guidance and competency scoping along with future curriculum design for appren�ceships with surveys and clinical ac�vity reviews.
NHSE Grant: to enhance and educate the profession.
Trade Union: to be used for the opera�on of The Trade Union
- 25 -
## **BRITISH & IRISH ORTHOPTIC SOCIETY**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **16 Unrestricted funds**
The unrestricted funds of the charity comprise the unexpended balances of dona�ons and grants which are not subject to speci�c condi�ons by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for speci�c purposes.
||**At 1**|**At 1**|**January**||**Incoming**||**Resources**||**Gains and**||**At 31**|
|---|---|---|---|---|---|---|---|---|---|---|---|
||||**2024**||**resources**||**expended**||**losses**|**December**||
||||||||||||**2024**|
||||**£**||**£**||**£**||**£**||**£**|
|General funds|||88,251||365,284||(408,032)||24,375||69,878|
|||||||||||||
|||||||||||||
|**Previous year:**|**At 1**||**January**||**Incoming**||**Resources**||**Gains and**||**At 31**|
||||**2023**||**resources**||**expended**||**losses**|**December**||
||||||||||||**2023**|
||||**£**||**£**||**£**||**£**||**£**|
|General funds|||99,493||357,346||(406,807)||38,219||88,251|
|||||||||||||
|||||||||||||
|**Analysis of net assets between**|**funds**|||||||||||
|||||||**Unrestricted**|||**Restricted**||**Total**|
||||||||**funds**||**funds**|||
||||||||**2024**||**2024**||**2024**|
||||||||**£**||**£**||**£**|
|**At 31 December 2024:**||||||||||||
|Tangible assets|||||||15,796||-||15,796|
|Investments|||||||-||270,516||270,516|
|Current assets/(liabili�es)|||||||54,082||704,232||758,314|
|||||||||||||
||||||||69,878||974,748||1,044,626|
|||||||||||||
|||||||||||||
|||||||**Unrestricted**|||**Restricted**||**Total**|
||||||||**funds**||**funds**|||
||||||||**2023**||**2023**||**2023**|
||||||||**£**||**£**||**£**|
|**At 31 December 2023:**||||||||||||
|Tangible assets|||||||19,973||-||19,973|
|Investments|||||||-||257,422||257,422|
|Current assets/(liabili�es)|||||||68,278||560,176||628,454|
|||||||||||||
||||||||88,251||817,598||905,849|
## **17 Analysis of net assets between funds**
- 26 -
**BRITISH & IRISH ORTHOPTIC SOCIETY**
_**FOR THE YEAR ENDED 31 DECEMBER 2024**_
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## **18 Related party transac�ons**
## **Remunera�on of key management personnel**
The charity considers key management personnel comprise of the trustees and external management agencies, to whom the general management and running of the Society is outsourced.
The Ar�cles of Associa�on allow payments to the employers of the Chair and Vice Chair whilst performing func�ons and du�es for the Society.
Payments were made in respect of V Greenwood (Chair - le� 2023) for £Nil (2023 - £25,527) and J Dowdney (Vice Chair) £10,602 (2023 - £20,743 ), C Murray (Chair) £28,408 (2023 - £28,408), D Podmore £5,916 (2023 - £5,513), H Haggerty £17,835 (2023 - £Nil). Payments were also made to four (2023 - twelve) other Consultants, trustees or council members as follows: £46,517 (2023 - £59,914).
Fees were payable to one (2023 - one) Business Manager during the year as follows:
Bri�sh Diete�c Associa�on - Management services £22,216 (2023 - £110,757)
The combined remunera�on of the key management personnel was:
||**2024**|**2023**|
|---|---|---|
||**£**|**£**|
|Aggregate compensa�on|131,494|250,862|
During the year, the charity collected fees of £139,202 (2023 - £125,511) from its members on behalf of the Bri�sh Orthop�c Society Trade Union.
- 27 -